X-109624625-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_012282.4(KCNE5):​c.396G>A​(p.Leu132Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000587 in 1,022,974 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. L132L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 25)
Exomes 𝑓: 0.0000059 ( 0 hom. 3 hem. )

Consequence

KCNE5
NM_012282.4 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.26

Publications

0 publications found
Variant links:
Genes affected
KCNE5 (HGNC:6241): (potassium voltage-gated channel subfamily E regulatory subunit 5) This gene encodes a member of a family of single pass transmembrane domain proteins that function as ancillary subunits to voltage-gated potassium channels. Members of this family affect diverse processes in potassium channel regulation, including ion selectivity, voltage dependence, and anterograde recycling from the plasma membrane. Variants of this gene are associated with idiopathic ventricular fibrillation and Brugada syndrome. [provided by RefSeq, Nov 2016]
ACSL4 (HGNC:3571): (acyl-CoA synthetase long chain family member 4) The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the cognitive disability or Alport syndrome. Alternative splicing of this gene generates multiple transcript variants. [provided by RefSeq, Jan 2016]
ACSL4 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Illumina, ClinGen, Orphanet
  • intellectual disability, X-linked 63
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant X-109624625-C-T is Benign according to our data. Variant chrX-109624625-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 3862723.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 6 Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012282.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNE5
NM_012282.4
MANE Select
c.396G>Ap.Leu132Leu
synonymous
Exon 1 of 1NP_036414.1Q9UJ90

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNE5
ENST00000372101.3
TSL:6 MANE Select
c.396G>Ap.Leu132Leu
synonymous
Exon 1 of 1ENSP00000361173.2Q9UJ90
ACSL4
ENST00000439581.1
TSL:3
n.387-304G>A
intron
N/A

Frequencies

GnomAD3 genomes
Cov.:
25
GnomAD4 exome
AF:
0.00000587
AC:
6
AN:
1022974
Hom.:
0
Cov.:
30
AF XY:
0.00000912
AC XY:
3
AN XY:
328962
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
23159
American (AMR)
AF:
0.00
AC:
0
AN:
21200
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16504
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26659
South Asian (SAS)
AF:
0.00
AC:
0
AN:
44971
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35244
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3504
European-Non Finnish (NFE)
AF:
0.00000742
AC:
6
AN:
808762
Other (OTH)
AF:
0.00
AC:
0
AN:
42971
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
25
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.5
DANN
Benign
0.93
PhyloP100
-1.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1196378792; hg19: chrX-108867854; API